AAAAAA
Results:
1-14
|
Results: 14
Authors:
KAVAKLI K
GRINGERI A
BADER R
NISLI G
POLAT A
AYDINOK Y
Citation: K. Kavakli et al., INHIBITOR DEVELOPMENT AND SUBSTITUTION THERAPY IN A DEVELOPING-COUNTRY - TURKEY, Haemophilia, 4(2), 1998, pp. 104-108
Authors:
CETINGUL N
ONIZ H
COGULU O
OZKINAY F
KAVAKLI K
KANTAR M
AYDINOK Y
POLAT A
NISLI G
OZTOP S
Citation: N. Cetingul et al., A NEW CHROMOSOMAL REARRANGEMENT IN ACUTE MYELOID-LEUKEMIA, Cancer genetics and cytogenetics, 107(2), 1998, pp. 153-154
Authors:
AYDINOK Y
COKER C
KAVAKLI K
POLAT A
KANTAR M
NISLI G
CETINGUL N
CETINER N
Citation: Y. Aydinok et al., URINARY ZINC EXCRETION AND ITS ASSOCIATION WITH RENAL TUBULER CELL DYSFUNCTION IN BETA-THALASSEMIA MAJOR, British Journal of Haematology, 102(1), 1998, pp. 53-53
Authors:
KAVAKLI K
OZACAR T
POLAT A
ZEYTINOGLU A
AYDINOK Y
KANTAR M
NISLI G
BILGIC A
CETINGUL N
Citation: K. Kavakli et al., HUMAN PARVOVIRUS-B-19 SEROPREVALANCE IN TURKISH HEMOPHILIAC CHILDREN, British Journal of Haematology, 102(1), 1998, pp. 96-96
Authors:
CETINGUL N
ONIZ H
YILMAZ D
KANTAR M
KAVAKLI K
AYDINOK Y
POLAT A
NISLI G
OZTOP S
Citation: N. Cetingul et al., SERUM ERYTHROPOIETIN LEVELS AND RECOMBINANT-HUMAN-ERYTHROPOIETIN USE FOR ANEMIA IN CHILDREN WITH CANCER, British Journal of Haematology, 102(1), 1998, pp. 336-336
Authors:
KAVAKLI K
NISLI G
OZCAN C
AVANOGLU A
ULMAN I
GOKDEMIR A
POLAT A
AYDINOK Y
Citation: K. Kavakli et al., SAFER AND MUCH CHEAPER CIRCUMCISION USING FIBRIN GLUE IN SEVERE HEMOPHILIA, Haemophilia, 3(3), 1997, pp. 209-211
Authors:
NISLI G
KAVAKLI K
AYDINOK Y
OZTOP S
CETINGUL N
Citation: G. Nisli et al., TERMINATION OF TRANSFUSION DEPENDENCE IN BETA-THALASSEMIA - 2-YEAR EXPERIENCE WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN, Pediatric hematology and oncology, 14(3), 1997, pp. 285-287
Authors:
KAVAKLI K
NISLI G
AYDINOK Y
OZTOP S
CETINGUL N
AYDOGDU S
YALMAN O
Citation: K. Kavakli et al., PROPHYLACTIC THERAPY FOR HEMOPHILIA IN A DEVELOPING-COUNTRY, TURKEY, Pediatric hematology and oncology, 14(2), 1997, pp. 151-159
Authors:
NISLI G
KAVAKLI K
AYDINOK Y
OZTOP S
CETINGUL N
Citation: G. Nisli et al., SERUM ERYTHROPOIETIN LEVELS IN PATIENTS WITH BETA-THALASSEMIA MAJOR AND INTERMEDIA, Pediatric hematology and oncology, 14(2), 1997, pp. 161-167
Authors:
NISLI G
KAVAKLI K
AYDINOK Y
OZTOP S
CETINGUL N
Citation: G. Nisli et al., BETA-THALASSEMIA ALLELES IN AEGEAN REGION OF TURKEY - EFFECT ON CLINICAL SEVERITY OF DISEASE, Pediatric hematology and oncology, 14(1), 1997, pp. 59-65
Authors:
KAVAKLI K
NISLI G
POLAT A
AYDINOK Y
OZTOP S
CETINGUL N
OZCAN C
AVANOGLU A
ULMAN I
GOKDEMIR A
Citation: K. Kavakli et al., FIBRIN GLUE FOR CIRCUMCISION IN SEVERE HEMOPHILIA, Thrombosis and haemostasis, 1997, pp. 1029-1029
Authors:
AYDINOK Y
OZTOP S
NISLI G
KAVAKLI K
Citation: Y. Aydinok et al., PREVALENCE OF BETA-THALASSEMIA TRAIT IN 1124 STUDENTS FROM AEGEAN REGION OF TURKEY, Journal of tropical pediatrics, 43(3), 1997, pp. 184-185
Authors:
NISLI G
KAVAKLI K
AYDINOK Y
OZTOP S
CETINGUL N
BASAK N
Citation: G. Nisli et al., RECOMBINANT ERYTHROPOIETIN TRIAL IN CHILDREN WITH TRANSFUSION-DEPENDENT HOMOZYGOUS BETA-THALASSEMIA, Acta haematologica, 98(4), 1997, pp. 199-203
Authors:
ALREFAIE FN
WONKE B
WICKENS DG
AYDINOK Y
FIELDING A
HOFFBRAND AV
Citation: Fn. Alrefaie et al., ZINC CONCENTRATION IN PATIENTS WITH IRON OVERLOAD RECEIVING ORAL IRONCHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE OR DESFERRIOXAMINE, Journal of Clinical Pathology, 47(7), 1994, pp. 657-660
Risultati:
1-14
|